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Abstract
Background: Accurate measurement of peripheral tissue perfusion is challenging but necessary to diagnose peripheral
vascular insufficiency. Because near infrared (NIR) radiation can penetrate relatively deep into tissue, significant attention
has been given to intravital NIR fluorescence imaging.
Methodology/Principal Findings: We developed a new optical imaging-based strategy for quantitative measurement of
peripheral tissue perfusion by time-series analysis of local pharmacokinetics of the NIR fluorophore, indocyanine green (ICG).
Time-series NIR fluorescence images were obtained after injecting ICG intravenously in a murine hindlimb ischemia model.
Mathematical modeling and computational simulations were used for translating time-series ICG images into quantitative
pixel perfusion rates and a perfusion map. We could successfully predict the prognosis of ischemic hindlimbs based on the
perfusion profiles obtained immediately after surgery, which were dependent on the preexisting collaterals. This method
also reflected increases in perfusion and improvements in prognosis of ischemic hindlimbs induced by treatment with
vascular endothelial growth factor and COMP-angiopoietin-1.
Conclusions/Significance: We propose that this novel NIR-imaging-based strategy is a powerful tool for biomedical studies
related to the evaluation of therapeutic interventions directed at stimulating angiogenesis.
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Introduction
Peripheral tissues are vulnerable to necrosis under conditions
that promote vascular insufficiency. Peripheral vascular insuffi-
ciencies are highly prevalent and usually result from diabetic
complications or systemic atherosclerosis [1–3]. Perfusion imaging
tools used to visualize the structure of the vasculature or functional
perfusion levels are useful in preclinical drug discovery research
and could have clinical applications [4,5]. For these purposes,
functional perfusion imaging is superior to structural vascular
imaging because prognosis of vascular insufficiency is directly
coupled to the functional perfusion level rather than to the
vascular structure [6]. For example, highly varied outcomes of the
ischemic hindlimbs might arise from differences in preexisting
collaterals [7]. Therefore, measurements of the functional tissue
perfusion through vessels including collaterals are required to
evaluate vascular insufficiency and predict the prognosis. In
addition, quantitative measurements of peripheral tissue perfusion
are required to enable comparative studies, e.g., evaluating the
effects of drugs in vivo or making clinical decisions based on patient
information. Minimizing the invasiveness of perfusion imaging
tools is a primary concern for clinical applications. Several
methods have been used to quantify perfusion, including
scintigraphic and positron emission tomography (PET) imaging
and magnetic resonance imaging (MRI). However, these methods
are too expensive for use in the diagnosis of tissue perfusion,
especially for animal studies. The standard quantitative method
for measuring perfusion in animals is microsphere perfusion;
however, this method is suitable for ex vivo, rather than in vivo,
measurements. Optical imaging, especially near infrared (NIR)
fluorescence imaging, has proven effective for in vivo imaging of the
vasculature and for estimation of functional perfusion [8].
For decades, indocyanine green (ICG) has been clinically used
as a NIR fluorophore for intravital imaging, a marker for liver
function [9], and a sensitizer for photodynamic therapy [10,11].
For vascular imaging, ICG is FDA-approved, and NIR spectra
enable deep tissue imaging [12,13]. In addition, intravenously-
injected ICG shows no extravasation except in abnormally
permeable vasculature because ICG binds to the major serum
protein, albumin [14]. Albumin-ICG complexes are segregated in
the liver with first-order pharmacokinetics and excreted via the
hepatobiliary pathway [15,16]. Nevertheless, the rapid clearance
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Recently, it was shown that the altered pharmacokinetics of ICG
can be useful for estimating cerebral oxygenation and hemody-
namics [17] and for measuring cerebral blood flow (CBF) [18–20].
Even though mathematical analysis was used to extract CBF from
ICG dynamics in these studies, a lack of quantitative information
limited the use of these techniques in the clinical setting [18]. The
main purpose of our study was to develop a new method for
functional and quantitative measurement of peripheral tissue
perfusion and to demonstrate the feasibility of this method.
Methods
Murine hindlimb ischemia model
BalB/cAnNCriBgi-nu nude male mice were obtained from
Charles River Japan Inc. (Yokohama, Japan). All mice were 7–8
weeks (15–20 g) of age at the time of study. Hindlimb ischemia
was induced by ligation and excision of the right femoral artery
and vein under ketamine–xylazine anesthesia. Animal care and
experimental procedures were performed under the approval of
the Animal Care Committees of KAIST.
For therapeutic angiogenesis studies, mice were divided into four
groups after induction of ischemia for intramuscular injection with
saline solution (20 mL with 0.9% NaCl and 0.1% bovine serum
albumen (BSA)) alone as a control or saline solution containing
COMP-angiopoietin-1 (cAng1) (20 mL of 200 ng/mL), vascular
endothelial growth factor (VEGF) (20 mL of 130 ng/mL), or both
cAng1 and VEGF (20 mL of 200 ng/mL cAng1 and 130 ng/mL
VEGF). Serial ICG perfusion imaging was performed immediately
after surgery and on postoperative day (POD) 3 and 7.
NIR fluorescence imaging
We used two optical systems for NIR fluorescence imaging:
Image station 4000 MM (Eastman Kodak Co., Rochester, NY,
USA) and a customized system developed for this study. The
customized imaging system employed a CCD digital camera
(PIXIS 1024; Princeton instruments, Princeton, NJ, USA) with a
custom-made 830-nm band-pass filter (Asahi Spectra USA,
Torrance, CA, USA) and 760-nm light-emitting diode arrays
(SMC760; Marubeni America, Sunnyvale, CA, USA).
For time-series ICG imaging, mice under ketamine–xylazine
anesthesia were injected with an intravenous bolus injection of
ICG (0.1 mL of 400 mmol/L; Sigma, St. Louis, MO, USA) into
the tail vein. ICG fluorescence images were obtained for 12 min in
20-s intervals (Kodak imaging system) or in 1-s intervals (custom
optical imaging system) immediately after injection. After the serial
imaging, a silhouette image of the mouse was taken under white
light to obtain the region of interest (ROI) mask of the ischemic
and normal hindlimbs.
In silico modeling
To identify the underlying relationships between the spatiotem-
poral ICG profiles and the perfusion rates in peripheral tissue, we
performed an in silico study that included mathematical modeling and
computational simulation analysis of ICG pharmacokinetics. To
quantitatively represent tissue perfusion, perfusion rate (%/min) was
defined as the fraction of blood exchanged per minute in the vascular
volume of the ROI. We assumed that blood volume through the
vasculature is time invariant during the imaging; therefore,
volumetric inflow and outflow were thought to be the same (Figure
S1A). To describe the regional ICG pharmacokinetics in vivo,t h er e a r
half of a mouse was divided into three compartments: the trunk, the
normal hindlimb, andthe ischemic hindlimb. Vascular input function
(VIF)ofICGinnormaltissueshasbeendescribedasauniexponential
function of ICG excretion by the liver because liver dynamics
dominate ICG excretion [16]. Therefore, ICG fluorescence intensity
in normal tissues could be described by the following equations:
FInor~Vde
t
t ð1Þ
and
t~
t1
2
ln2
, ð2Þ
where FInor is the ICG fluorescence intensity in the VIF of normal
tissues, Vd, is the vascular density, t is time, t is the time constant for
systemic dynamics, and t1/2 is the ICG half-life in the trunk.
The half-life of ICG decay varies, ranging from 3 to 5 min,
according to idiosyncratic variations in hepatic function [9],
anesthetizing conditions, and hemodynamic status. To normalize
the variations in the excretion rate, we introduced ‘t’ for all equations
mentioned below.
The change in concentration of the ROI can be described using
Fick’s law:
changes in the concentration fg ~ inflow fg { outflow fg
Therefore, the dynamics of ICG fluorescence intensity in the
ischemic hindlimbs, FIisc, are a function of time and are
represented by
dFIisc t ðÞ
dt
~P:FInor{P:FIisc, ð3Þ
where parameter ‘P’ represents the perfusion rate of the ischemic
hindlimbs. The FIisc is defined as follows using Equations 1 and 3:
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Because the dynamics of ICG fluorescence intensity after tissue
injection showed a bell-shaped curve, the differential value of FIisc
is assigned as zero at the time-to-peak (Tmax). Therefore, the
differential value of equation 4 is zero at the Tmax.
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From equation 5, we could derive equation 6 and calculate the
perfusion rate (P) of each pixel in the ROI using two parameters, the
Tmax of each pixel and ICG half-life in the trunk. The simulation for
the temporal ICG dynamics was run with different perfusion rate
values (Figure S1B), which was consistent with actual ICG dynamics
(see Figure 1C). The relationships among the ICG half-life, the time-
to-peak, and the perfusion rate are shown in Figure S1C and D.
Image analysis
ROI masks of ischemic and normal limbs were drawn on the
silhouette image to extract regions corresponding to limbs in the
acquired time-series NIR fluorescence images. Likewise, the square
Imaging of Tissue Perfusion
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calculating the systemic half-life of ICG. Image processing and data
analysis were performed using Visual C
++ (version 6.0; Microsoft,
Redmond, WA, USA) and Matlab (MathWorks, Natick, MA, USA).
The half–life of ICG was measured in the square mask region
on the trunk and the time-to-peak of each pixel was determined to
obtain the perfusion rate of a pixel in the ROI. The pixel number
of a ROI in a limb was typically around 1200–1500. The perfusion
rate in each pixel was then calculated using the equation derived
by modeling. The result was visualized as a pseudocolor-coded
perfusion map or a histogram.
To determine the probability of necrosis, necrotic regions in the
ischemic limbs were assessed on POD 7. Perfusion rates that were
measured 4 h post-op were analyzed in both the necrotic and non-
necrotic regions. The correlation between the regional perfusion
rate (average perfusion rate of 262 pixels) and the necrosis of this
region was calculated. The relationship between necrosis deter-
mined at POD 7 and the regional perfusion rate measured
immediately after surgery was obtained based on data from 20
mice. A necrosis map was generated by mapping the predictive
necrosis of individual regions as a color-coded picture.
Histological analysis
Vessel density within the calf muscles of the ischemic limbs was
quantified by histological analysis. The ischemic muscles were
perfused with 4% (w/v) paraformaldehyde (Sigma) and embedded
Figure 1. Quantitative measurement of perfusion rate based on spatiotemporal ICG dynamics. (A) Contrast NIR fluorescence
angiography. (B) Temporal sequence of ICG fluorescence in the hindlimb ischemia model. The number indicates the time after ICG injection. (C)
Temporal dynamics in the regions indicated with boxes in D are plotted. Relative fluorescence units (R.F.U.) were normalized to the maximal intensity.
(D) Perfusion map reconstructed based on the time-series ICG images shown in B. (E) Histogram of perfusion rates in each limb for the regions
indicated by the dotted box in D. The arrows indicate two perfusion rate peaks in the normal limb. (F) Photographic image of a normal hindlimb after
skin excision to expose femoral vessels (right). Perfusion map of the limb (left). (H) Histogram of perfusion rates of the total hindlimb is indicated by
the blue line, and the red line depicts the perfusion rates of the ROIs marked by the red line on femoral vessels.
doi:10.1371/journal.pone.0004275.g001
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with hematoxylin–eosin (H&E) and also double-stained with anti-
CD31 antibody (Chemicon, Temecula, CA, USA) and a
monoclonal anti-a-smooth muscle-actin (a-SMA) antibody (Sigma)
conjugated to fluorescein isothiocyanate (FITC). Proteins immu-
noreactive with the anti-CD31 antibody were stained with a
hamster anti-mouse IgG antibody conjugated with rhodamine
(Jackson Laboratories, West Grove, PA, USA). The stained
sections were visualized by confocal microscopy (Axiovert LSM
510 META; Zeiss, Oberkochen, Germany). Vessel density was
expressed as the number of a-SMA and CD31 double-positive
micro- (16–63 mm in diameter) and macrovessels (.63 mmi n
diameter) per high-power field (magnification6400) [21].
Laser Doppler imaging (LDI)
Mice were scanned using LDI (MLDI5063; Moor Instruments
Ltd., Devon, UK) after ICG perfusion imaging at POD 0. Three
consecutive scans were performed until blood flow measurements
were stable. The images were subjected to computer-assisted
quantification of blood flow.
Micro-CT angiography
Mice were placed in an induction chamber with 4% isofluorane
in oxygen to induce anesthesia. After anesthetization, mice were
injected with PEG-conjugated gold nanoparticles (400 mLo f
0.2 mol/L) intravenously and placed on a volumetric CT scanner
(NFR-MXSCAN-G90; NanoFocusRay, Iksan, Korea) [22]. While
scanning, the mice remained anesthetized under 1.5% isofluorane
in oxygen. In total, 600 images were acquired at 65 kVp, 55 mA,
and 800 ms per frame. Images were reconstructed using the
Feldkamp cone-beam reconstruction algorithm. The reconstruc-
tion image size was 102461024 pixels, and 512 slices were
acquired. The final reconstructed data were converted to the
Digital Imaging and Communications in Medicine (DICOM)
format to make three-dimensional (3-D)-rendered images using 3-
D-rendering software (Lucion; MeviSYS, Seoul, Korea).
Statistical analysis
Data are expressed as means6SEM. Statistical significance was
assessed by Student’s two-tailed t-test for two groups or by one-
way ANOVA and Bonferroni post hoc test for three or more groups.
Results
Estimation of tissue perfusion based on time-series
analysis of ICG pharmacokinetics
The feasibility of NIR fluorescence imaging [8] was examined to
monitor peripheral tissue perfusion using albumin microspheres
conjugated with the NIR fluorophore ICG (Method S1) [23].
Contrast NIR fluorescence angiography showed obvious differences
in maximal fluorescence intensity between normal and ischemic
hindlimbs (Figure 1A). Even though contrast optical imaging
distinguished well-perfused from hypoperfused tissues, it only
provided qualitative information. Because the local concentration
of ICG is dependent on regional tissue perfusion, we measured the
spatiotemporal dynamics of ICG pharmacokinetics by obtaining
time-series images of free ICG fluorescence [17]. As expected, ICG
dynamics in normal hindlimbs showed a rapid time-to-peak of
around 20 s after ICG injection and an exponential decay of ICG
fluorescence (Figure 1B, upper panel). In contrast, ischemic limbs
showed markedly altered dynamics of ICG fluorescence compared to
controls and a remarkably delayed time-to-peak and clearance
(Figure1B,lowerpanel).Wealsoobservedconsiderabledifferencesin
the ICG dynamics between different regions in the same ischemic
hindlimb (Figure 1C), suggesting spatial heterogeneity of perfusion in
the peripheral tissue. Based on the equation obtained in silico,w e
translated the temporal ICG dynamics of each pixel into the
perfusion rate and constructed a perfusion map (Figure 1D). This
perfusion map showed the spatial distribution of perfusion rates with
high spatial resolution. Histogram analysis showed a bimodal
distribution of perfusion rates in the normal limb, while only one
peak with a lower perfusion rate was observed in the ischemic
hindlimb (Figure 1E). The two peaks of perfusion in the normal
hindlimb appeared to correspond to macrovasculature regions with
high perfusion rates and microvascular compartments with lower
perfusion rates. To confirm whether the right peak of the bimodal
distribution corresponded to macrovascular regions, we removed the
skin of the calf to reveal the femoral artery and vein and performed
ICG perfusion imaging (Figure 1F). The exposed femoral artery and
vein were distinguishable with higher perfusion rates compared to the
surrounding area in the perfusion map (Figure 1F, right panel).
Moreover, the perfusion rates of the ROI corresponding to the
exposed macrovascular regions matched the right peak of the
bimodal distribution in the histogram of the normal limb(Figure1G).
Therefore, the histogram analysis of perfusion clearly indicated that
the induction of ischemia abolished macrovasculature perfusion and
significantly reduced microvascular perfusion.
Functional levels of perfusion by preexisting collaterals
determine the prognosis of hindlimbs after induction of
ischemia
To validate ICG dynamic perfusion imaging analysis, we
estimated the tissue perfusion immediately after induction of
ischemia (Figure 2A). Normal hindlimbs demonstrated a perfusion
rate of 475619%/min, while the perfusion rate of ischemic
hindlimbs was 5666%/min (12.2% of the normal hindlimbs).
Considerable variability was observed in the outcome of the
ischemic hindlimbs, which might have arisen from differences in
preexisting collaterals [7]. To validate our method, we investigated
the correlation between the initial perfusion rates of the ischemic
tissues and the prognosis, both of which are dependent on
preexisting collaterals. The animals were classified into three
groups according to the severity score of limb necrosis (score
0=no necrosis; score 1=toe necrosis; score 2=foot necrosis; score
3=ankle necrosis; score 4=autoamputation of the entire leg.
Moderate necrosis includes scores 1 and 2 and severe necrosis
includes scores 4 and 5.), which was determined by visual
inspection on POD 7. These groups included no necrosis (16%),
moderate necrosis (40%), and severe necrosis (46%; Figure S2).
We then compared the perfusion rates of these three groups from
the ischemic limbs immediately after surgery (Figure 2B). In 16%
of the animals with the best prognosis, the perfusion rate of the
ischemic hindlimbs was significantly higher compared to other
groups; the average perfusion rates of the groups with moderate
and severe necrosis were 19.4 and 4.11%/min, respectively
(Figure 2B). However, the representative data of the ischemic/
normal blood flow ratio using LDI did not provide enough
sensitivity to show correlations between the initial blood flow and
the necrosis level in the ischemic limbs. Since the preexisting
vasculature appeared to contribute significantly to the prognosis,
we questioned whether the perfusion map obtained immediately
after surgery could precisely predict future necrosis. To address
this, we determined the relationship between the probability of
regional tissue necrosis on POD 7 and the given perfusion rate of
the corresponding region after operation (Figure 2C). This
relationship was expressed in an inverse sigmoidal function. By
mapping perfusion rates with necrosis probability, we generated a
color-coded necrosis map to display the spatial distribution of
Imaging of Tissue Perfusion
PLoS ONE | www.plosone.org 4 January 2009 | Volume 4 | Issue 1 | e4275Figure 2. Necrosis predictability of ICG dynamic perfusion imaging. (A) Average limb perfusion rates of the normal and ischemic hindlimbs
at POD 0 (postoperative day 0; Post-Op.). The gray lines indicate the mean of each group. The P value is shown (Student’s t-test, n=24). (B)
Correlation between average limb perfusion rates in the ischemic limbs at POD 0 (black boxes and whiskers) and limb necrosis levels at POD 7.
Bonferroni post hoc test applied to the significant effect of groups (ANOVA F2,44=58.358, P,0.001). *, P,0.001. **, P=0.054. The y-axis is in log scale.
The gray boxes and whiskers show a relationship between the ischemic/normal laser Doppler blood flow ratio at POD 0 and limb necrosis levels at
POD 7. (ANOVA F2,16=0.465, P=0.636). (C) Sigmoidal relationship between regional perfusion rates of the ischemic hindlimbs at POD 0 and necrosis
probability of the corresponding region at POD 7. Graphs were drawn from data of 70,714 regions from 20 mice (Boltzmann sigmoidal fit, R
2=0.998,
P,0.001). The x-axis is in log scale. (D) Comparison of diagnostic predictability between LDI and ICG perfusion imaging. For three representative mice
with different prognoses, LDI images, perfusion maps, and necrosis maps at POD 0 are shown along with pictures of the ischemic limbs at POD 7. The
region for the necrosis map from the corresponding area in the perfusion map is indicated by the white dotted boxes.
doi:10.1371/journal.pone.0004275.g002
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predicted levels of necrosis to the actual necrosis levels in ischemic
limbs verified the feasibility and accuracy of the necrosis map. The
perfusion maps of representative mice showed considerable
contrasts in ischemic limb perfusion rates, and the necrosis maps
showed a remarkably high correlation with the actual necrotic
regions that were determined on POD 7 (Figure 2D). To further
validate the sensitivity of our newly developed tool using ICG
dynamic imaging, we compared the perfusion map to conven-
tional LDI, the current ‘‘gold standard’’ for in vivo blood flow
measurements (Figure 2D, left panel) [24]. The LDI images of the
three representative mice could only demonstrate overall qualita-
tive decreases in the levels of perfusion in the ischemic limbs and
could not, on a more quantitative level, differentiate between levels
of perfusion (Figure S3). These results collectively indicate the
superior sensitivity of ICG dynamic optical imaging, which is
sensitive enough to predict future necrosis of ischemic tissues.
Vascular endothelial growth factor and COMP-ang1
synergistically improve perfusion and subsequent
prognosis of ischemic hindlimbs
For therapeutic angiogenesis studies, 70 mice were divided into
four groups. The initial perfusion rates of the ischemic limbs were
not significantly different among groups (ANOVA, F3,33=0.667,
p=0.578, Figure S4). After intramuscular injection of angiogenic
factors in the ischemic limbs, follow-up ICG perfusion imaging
was serially performed on POD 3 and 7. As expected, the
probability of necrosis in regions with low perfusion rates (2–60%/
min) was significantly improved by treatment with VEGF, cAng1,
or both (Figure 3A). Intergroup comparisons of time-dependent
increments in perfusion rates clearly demonstrated synergistic
therapeutic effects of VEGF and cAng1, especially between POD
3 and 7 (Figure 3B and Figure S5); this was consistent with results
from our previous study [25]. The representative comparison
shows that combined treatment with VEGF and cAng1 improved
perfusion and the subsequent prognosis of the ischemic hindlimbs
(Figure 3C). In the control animals, the amount of necrotic tissue
accurately matched the necrosis predicted by postoperative (post-
op) perfusion measurements. Slightly diminished perfusion was
initially observed in the combined treatment animal, which was
predicted to have a poorer prognosis compared to the control;
however, the final outcome was much better than that of the
control, indicating a protective effect of combined treatment.
Histogram analysis showed that the unimodal peak shifted to the
right after surgery and was almost completely restored to the level
of the normal hindlimb, suggesting a dominant effect of
proangiogenic factors on the microvasculature.
Arteriogenesis partly mediates improvement of tissue
perfusion
As previously indicated, some animals never developed tissue
necrosis even though identical surgical protocols to induce
ischemia were used. Therefore, uneven distribution of such
nonresponsive animals into the study groups can severely distort
the results [26]. Since our method can quantitatively determine
the efficacy of the treatment on the perfusion rate rather than
grading visible necrosis, we tested whether our method was also
useful for evaluating the efficacy of the proangiogenic factors in
this nonresponsive group (Figure 4). The perfusion rate of a
representative case in the control group at post-op was measured
as 56%/min; hence, the ischemic limb was predicted to be
salvaged. The limb perfusion rate increased to 183%/min on
POD 3 and 227%/min on POD 7 (Figure 4, upper left panel). The
histogram analysis of the ischemic limb also showed a gradual
time-dependent shift to the right; however, the histogram of
perfusion rates on POD 7 showed incomplete recovery when
compared to the pre-op level (Figure 4, upper right panel). In a
representative case in the combination treatment group, the post-
op limb perfusion rate was estimated to be 68%/min, and no
necrosis was predicted. The limb perfusion rate increased to
161%/min by POD 3 and increased to 364%/min by POD 7
(Figure 4, lower left panel). The histogram showed almost
complete recovery of perfusion by POD 7 when compared to
the initial level of perfusion before surgery; notably, there was a
recovery of macrovascular conductance on POD 7 even though
the level was lower than that of the basal level, suggesting
regeneration of the macrovasculature by combined treatment of
VEGF and cAng1 (Figure 4, lower right panel). Likewise, the
postmortem histological study demonstrated that PECAM and a-
SMA double-positive vessels increased significantly in number and
size in the intermuscular septa and muscle fibers in the combined
treatment group compared to the control group (Figure 5A).
Quantitative measurements showed a 19.7-fold increase in
macrovascular density, while the combined treatment increased
the density of both the macro- and microvessels (Figure 5B).
Moreover, micro-CT scans depicted more than three macrovessels
(.150 mm in diameter) in the calf of the treated animals on POD
7 (Figure 5C, left panel); there were only thin macrovessels (smaller
than 100 mm) in the calf of the control animals (Figure 5C, right
panel). Collectively, these results suggest that combined treatment
with VEGF and cAng1 increases perfusion and improves the
outcome of the ischemic hindlimbs partly via induction of
arteriogenesis and microvascular angiogenesis.
Discussion
In this paper, we propose a novel NIR imaging method for the
quantitative measurement of perfusion in peripheral tissues using
planar reflectance imaging, which is simpler to implement
compared to the tomographic method, by introducing mathemat-
ical modeling and a computational simulation. The validity of this
novel method was evaluated using a murine model of hindlimb
ischemia and therapeutic interventions directed at stimulation of
angiogenesis. We showed that time-series imaging of intravenously
injected ICG can provide quantitative information regarding
peripheral tissue perfusion precisely enough to predict the
prognosis of the ischemic tissues and to verify the therapeutic
effects of proangiogenic factors such as VEGF and cAng1. For
analysis of ICG dynamics, we designed a biologically meaningful
mathematical model.
Previous studies that used ICG dynamics to estimate blood
perfusion failed to provide quantitative information that was
required for interindividual comparison. In those studies, blood
perfusion was estimated based on the maximal fluorescence
intensities of injected ICG, which depend heavily on the
heterogenous optical properties of regional tissues [17,18].
Moreover, static reflectance images from different animals or
from the same animal at different time points are generally
insufficient for yielding quantitative insights, because the fluores-
cence intensity depends on the depth of the signal and the volume
and optical properties of the tissue. Thus, we performed time-
series NIR fluorescence imaging to obtain the spatiotemporal
dynamics of ICG and translated the time-series images into
quantitative perfusion maps. Furthermore, we compensated for
idiosyncratic variations in ICG pharmacokinetics to obtain
quantitative information on perfusion rates, because the idiosyn-
cratic variation of ICG dynamics depends on the level of
Imaging of Tissue Perfusion
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hepatic clearance that can affect the evaluation of perfusion rate.
This quantitative information enabled us to predict the necrotic
profile of ischemic tissues.
The necrosis profiles of the ischemic limbs were variable among
subjects even when the same surgery protocol and the same strain
of animals were used [26]. Necrosis profiles of the ischemic
hindlimbs are considered to be determined by two main factors:
Figure 3. Synergistic proangiogenic effects of VEGF and cAng1. (A) Correlations between necrosis probability and regional perfusion rates
were determined. (B) Differences in perfusion rates according to the time period are indicated for each group. ANOVA and Bonferroni post hoc test
applied to the significant effect of groups on D (POD 3 - POD 7), (ANOVA F3,33=4.890, P=0.006).
{{, P=0.004 vs. BSA control. Paired t-tests were
performed for each intragroup comparison. (C) Representative examples of BSA control and combined treatment groups.
doi:10.1371/journal.pone.0004275.g003
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[27,28]. Variability of necrosis profiles between subjects could be
caused primarily by differences in the preexisting collateral
circulation, because the substrates of vascular genesis are
preexisting collateral arteries [29]. Therefore, we made two
predictions. First, if the perfusion rate measured at post-op
represents the preexisting collateral circulation, we predicted that
this would show a significant relationship with future necrosis of
the ischemic limb. As expected, the regional perfusion rate showed
a significant inverse (sigmoidal shape) relationship with the
probability of necrosis of the region. Second, we predicted that
aiding angiogenesis by treatment with proangiogenic factors would
alter the necrosis profile based on the preexisting collateral
circulation. Significantly, treatment with the proangiogenic factors
VEGF and cAng1 improved the necrosis profile.
Our method has several advantages for analyzing the perfusion
and prediction ofnecrosis compared to conventional methods.First,
quantitative measurement of tissue perfusion can allow interindi-
vidual comparative analysis of tissue perfusion. Second, this highly
sensitive and quantitative measurement of perfusion can be used to
equally distribute ischemic hindlimb model mice in control and
experimental groups, which would lessen data distortion and
decrease the variability of the experimental results. We have
observed that the prognosis of ischemic tissues from animals
subjected to identical surgical protocols varies considerably. This
results in intrinsic data heterogeneity, which could severely
misrepresent the outcome of drug interventions. Third, changes in
perfusion due to proangiogenic factors in ischemic tissues can be
evaluated and arteriogenic processes can be differentiated from
angiogenesis because our method can classify conductance through
the macrovasculature. We observed that combined treatment with
VEGF and cAng1 restored the bimodal histogram perfusion rate
pattern in the ischemic limbs, reflecting the emergence of
macrovascular components. Histological and CT-angiogram anal-
ysis also showed that combined treatment with VEGF and cAng1
induced arteriogenesis along with angiogenesis. These results
suggest that ICG dynamic perfusion imaging might be applied to
differentiate macroangiopathy from microangiopathy.
Our method has several potential limitations as well. First,
induction of ischemia transiently changes vascular permeability
and dilatation, which play roles in functional recovery from acute
hindlimb ischemia [30]. Our method might underestimate
perfusion rates in cases of increased vascular permeability because
delayed washout kinetics of ICG as a result of leakage are typically
interpreted as decreased perfusion. Moreover, our method cannot
distinguish between perfusion changes due to blood flow versus
microvessel density. Therefore, it is important to control the
physiologic factors that can affect blood flow such as blood
Figure 4. Therapeutic effects of VEGF and cAng1 on tissue perfusion. Representative cases of BSA control and combined treatment groups.
doi:10.1371/journal.pone.0004275.g004
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PLoS ONE | www.plosone.org 8 January 2009 | Volume 4 | Issue 1 | e4275Figure 5. Arteriogenic effects of VEGF and cAng1. (A) Confocal micrographs of calf muscle sections from ischemic limbs treated with VEGF/
cAng1 and BSA. Magnification, 2006. Bar=100 mm. (B) Macro- and microvessel densities were evaluated in the calf muscles. The number of vessels
was expressed as vessels/mm
2. Data from six fields of the four samples were averaged. Student’s t-test was applied. (C) Micro-CT angiography. The
arrows indicate macrovessels in the calf.
doi:10.1371/journal.pone.0004275.g005
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measurement of tissue perfusion. Second, even though NIR can
penetrate biological tissues deeply, the depth of NIR penetration
nonetheless restricts measurement of perfusion to peripheral
tissues. For analysis of deep-seated organs, endoscope-coupled
technology might help to overcome this limitation. Finally, it is
technically difficult to estimate accurate perfusion rates for normal
tissues, especially in the case of normal tissues that have very fast
ICG kinetics. For accurate measurements of such fast kinetics, the
images with maximal intensity should be captured, which
correspond to images of the time-to-peak. Since the 20 s time-
series imaging of the Kodak imaging system is too long an interval
to capture the time-to-peak of normal limbs, we developed a
customized NIR fluorescence imaging system that can shorten the
interval to as little as 1 s. In this way, we were able to capture the
peak intensity successfully even in normal limbs. In addition we
confirmed that these two imaging methods provided basically the
same results when estimating perfusion rates in ischemic limbs,
which showed slower ICG kinetics.
In summary, our results indicate that ICG dynamic perfusion
imaging can quantitatively evaluate perfusion in peripheral tissues.
Moreover, this imaging technology could be used to predict future
necrosis profiles and evaluate angiogenesis. ICG perfusion imaging
can be a cost- and time-efficient tool for diagnosis of patients with
peripheral vascular insufficiencies. Although further studies
evaluating ICG imaging for clinical applications are needed, we
believe that this revolutionary imaging method may provide new
impulse to the multidisciplinary analysis of biomedical imaging
and may contribute to the development of clinical diagnostic
techniques for peripheral vascular disease.
Supporting Information
Method S1 Contrast NIR fluorescence angiography
Found at: doi:10.1371/journal.pone.0004275.s001 (0.02 MB
DOC)
Figure S1 (A) Schematic model diagram for in silico analysis:
simplified model for local tissue perfusion including volumetric
inflow (vi), volumetric outflow (vo), and blood volume of the
vasculature (Vv). (B) Simulated results for temporal ICG dynamics
with different perfusion rates. Maximal intensity has been
normalized. R.F.U., relative fluorescence units. (C) Simulated
ICG dynamics with different perfusion rate values and half-lives of
ICG. (D) Two parameters that determine the decay phase in ICG
dynamics. The graph shows that both the half-life of ICG and the
perfusion rate contribute to the time-to-peak of ICG dynamics.
Found at: doi:10.1371/journal.pone.0004275.s002 (1.37 MB TIF)
Figure S2 Natural course of ischemic limbs. Severity score of
ischemic hindlimb necrosis was assessed using the following scale:
score 0=no necrosis; score 1=toe necrosis; score 2=foot necrosis;
score 3=ankle necrosis; score 4=autoamputation of the entire
leg. Moderate necrosis includes scores 1 and 2 and severe necrosis
includes scores 4 and 5. The prognosis of the ischemic hindlimbs
of each group was plotted with the severity score over time. Note
that tissue necrosis occurred mainly within 7 days after surgery.
Found at: doi:10.1371/journal.pone.0004275.s003 (0.36 MB TIF)
Figure S3 Comparison of the tissue perfusion from a collection
of ROIs between the ICG perfusion imaging and LDI. Note the
LDI cannot differentiate between the levels of perfusion especially
in the low perfusion section, from 1% to 100%/min. In this
section, the broad range of the necrosis probability was distributed
from 0% to 90%.
Found at: doi:10.1371/journal.pone.0004275.s004 (0.16 MB TIF)
Figure S4 Post-operative perfusion rates in the ischemic limbs of
four groups of mice that were distributed evenly for therapeutic
angiogenesis study. Note the non-significant difference in perfusion
rates at post-op among the groups [ANOVA, F(3,33)=0.667,
p=0.578, Bonferroni Post hoc: p=1 among all groups].
Found at: doi:10.1371/journal.pone.0004275.s005 (0.16 MB TIF)
Figure S5 Each line indicates the time-dependent change of the
average perfusion rate of ischemic hindlimbs from each mouse.
Found at: doi:10.1371/journal.pone.0004275.s006 (0.33 MB TIF)
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